BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $100 at Citi Following 4Q
Tweet Send to a Friend
Citi raised its price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $100.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
